Correlation Between Reviva Pharmaceuticals and Enveric Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Enveric Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Enveric Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Enveric Biosciences, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Enveric Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Enveric Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Enveric Biosciences.

Diversification Opportunities for Reviva Pharmaceuticals and Enveric Biosciences

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between Reviva and Enveric is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Enveric Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enveric Biosciences and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Enveric Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enveric Biosciences has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Enveric Biosciences go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Enveric Biosciences

Given the investment horizon of 90 days Reviva Pharmaceuticals Holdings is expected to generate 2.49 times more return on investment than Enveric Biosciences. However, Reviva Pharmaceuticals is 2.49 times more volatile than Enveric Biosciences. It trades about 0.17 of its potential returns per unit of risk. Enveric Biosciences is currently generating about -0.51 per unit of risk. If you would invest  98.00  in Reviva Pharmaceuticals Holdings on September 2, 2024 and sell it today you would earn a total of  26.00  from holding Reviva Pharmaceuticals Holdings or generate 26.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Reviva Pharmaceuticals Holding  vs.  Enveric Biosciences

 Performance 
       Timeline  
Reviva Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Reviva Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Enveric Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enveric Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Reviva Pharmaceuticals and Enveric Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Reviva Pharmaceuticals and Enveric Biosciences

The main advantage of trading using opposite Reviva Pharmaceuticals and Enveric Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Enveric Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enveric Biosciences will offset losses from the drop in Enveric Biosciences' long position.
The idea behind Reviva Pharmaceuticals Holdings and Enveric Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios